
CAS: 1000676-41-4
Trier par
2 produits concernés.
Lirilumab
CAS :Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervicalDegré de pureté :95% - 98.40% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :145.52 kDa